NVA Announces $10 Million Donation to Fund Clinical Trials and Pioneering Breakthroughs in Specialty and Emergency Medicine
August 18, 2022National Veterinary Associates (“NVA”), a leading global pet care organization and community of more than 1,500 veterinary hospitals and pet resorts, is pleased to announce a $10 million donation to Ethos Discovery, a nonprofit incubator dedicated to advancement in veterinary medicine.
Read More-
Nationwide, Multi-center, Prospective Study of Canine Splenic Hemangiosarcoma Complete
January 15, 2019Hemangiosarcoma is one of the most malignant forms of cancer in dogs and CHAMP is the first nationwide, multicenter, prospective study of canine splenic hemangiosarcoma, which is a cancer of the blood vessels often affecting the spleen.
Read More -
Development Collaboration to Prevent Cancer Recurrence
December 18, 2018First-Ever Human Health and Animal Health Drug Development Collaboration to Prevent Cancer Recurrence. Ethos Veterinary Health and Vuja De Sciences to utilize novel cellular assays of cancer metastasis and integration of pet dogs with cancer to empower innovative metastasis-focused drug development collaboration.
Read More -
ACI and Ethos Veterinary Health Form New Clinical Trial Network
March 8, 2017Animal Clinical Investigation (ACI) and Ethos Veterinary Health (Ethos) have formed a strategic alliance offering a new mechanism to deliver market approval of pharmaceuticals and therapeutics in Animal Health. This relationship offers a unique opportunity for collaboration with organizations in the pharmaceutical industry, diagnostic developers and medical device companies.
Read More -
Ethos Diagnostic Science Conducts Accuracy Testing for Samsung
February 7, 2017Samsung plans to extend the number of new testing analytes for In-Vitro Diagnostic (IVD) devices and also add veterinary products for imaging devices such as ultrasound system to establish a total solution for pet healthcare market which is likely to show a sustainable growth.
Read More
Loading